Formulation useful for the inhibition of massive release of cerebral glutamate
US5242915A · kind A · utility
32Cited by
1References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 20, 1992 |
| Grant date | Sep 7, 1993 |
| Priority date | — |
| Expiry date | May 20, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method useful for the treatment or prevention of diseases caused by a massive release of cerebral glutamate, in particular epilepsy and dementia, and pharmaceutical formulations therefor, which comprise, as an active ingredient, a therapeutically effective amount of methyl (+)-(4S)-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2,3-b]pyr idine-5-carboxylate (S-312-d).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.